ArticleHeliyon2025
Development of a photoacoustic acquisition system and their proof-of-concept for hemoglobin detection.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, Organ-on-a-Chip (OoC) platforms have arisen as an increasingly relevant experimental tool for successfully replicating human physiology and disease. However, there is a lack of a standard technology to monitor the OoC parameters, especially in a non-invasive and label-free way. Photoacoustic (PA) systems can be considered an alternative and accurate assessment method for OoC platforms. PA systems combine an illumination source to excite the sample molecules, with an ultrasound sensor to measure the generated ultrasonic waves, combining the advantages of optics and acoustic methodologies to safely acquire tridimensional signals and images at various depths. This work is focused on the design, implementation and test of an acquisition electronics circuit, based on the PA principle, for hemoglobin (Hb) detection, aiming towards a future integration within an OoC platform. Based on the measured frequency response of commercial piezoelectric transducers, an electronics design comprising a differential charge amplifier and a band-pass filter was developed. Experimentally it was verified Hb detection for concentrations of Hb between 2.5 and 10 mg/mL in aqueous solutions, roughly 48 times lower than the typical
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.